title: HLA class II induction and cellular infiltration are effectively suppressed by triple therapy in renal allografts.
authors.affiliation: Nuffield Department of Surgery, University of Oxford, John Radcliffe Hospital, UK.
authors.forename: D L
authors.initials: DL
authors.lastname: McWhinnie
authors.forename: S V
authors.initials: SV
authors.lastname: Fuggle
authors.forename: L S
authors.initials: LS
authors.lastname: Azevedo
authors.forename: R M
authors.initials: RM
authors.lastname: Jones
authors.forename: P J
authors.initials: PJ
authors.lastname: Morris
mesh_terms: D001379:Azathioprine / Q000008:administration & dosage; D001707:Biopsy, Needle; D003524:Cyclosporins / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006681:HLA-D Antigens / Q000276:immunology*; D006801:Humans; D007111:Immunity, Cellular; D007165:Immunosuppression Therapy; D007668:Kidney / Q000276:immunology; D016030:Kidney Transplantation; D011239:Prednisolone / Q000008:administration & dosage
chemical_list: D003524:Cyclosporins; D006681:HLA-D Antigens; D011239:Prednisolone; D001379:Azathioprine